PhRMA Scurries To Prepare For PDUFA: Currie Moves Up To Chief Lobbyist
Executive Summary
PhRMA's federal lobbying efforts heading into the Prescription Drug User Fee Act reauthorization deliberations will be led by one of the key staffers during the 1997 FDA Modernization Act debate.